Familial Alzheimer disease
MONDO:0100087A degenerative disease of the brain that causes gradual loss of memory, judgment, and the ability to function socially. About 25% of all Alzheimer disease is familial (more than 2 people in a family have AD). When Alzheimer disease begins before 60 or 65 years of age (early-onset AD) about 60% of the cases are familial (also known as Early-onset familial AD). These cases appear to be inherited in an autosomal dominant manner.
Also known as: Alzheimer disease, familial, FAD, GARD:0000632
58 clinical trials for this condition and its sub-types, 13 tagged with Familial Alzheimer disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Familial Alzheimer disease
-
Early-onset autosomal dominant Alzheimer disease 31 trials · 37 incl. sub-types
14 sub-types
- Alzheimer disease 3 5 trials
- Alzheimer disease type 1 4 trials
- Alzheimer disease 4 3 trials
- Alzheimer disease 10 1 trial
- Alzheimer disease 11 1 trial
- Alzheimer disease 12 1 trial
- Alzheimer disease 13 1 trial
- Alzheimer disease 14 1 trial
- Alzheimer disease 5 1 trial
- Alzheimer disease 6 1 trial
- Alzheimer disease 7 1 trial
- Alzheimer disease 8 1 trial
- Alzheimer disease without neurofibrillary tangles 1 trial
- Alzheimer disease, familial early-onset, with coexisting amyloid and prion pathology 0 trials
-
Alzheimer disease 2 11 trials
-
Could flickering lights and tones help fight Alzheimer's? major trial underway
Disease control CompletedThis study tests a device that delivers specific light and sound patterns to the brain, aiming to slow the progression of mild-to-moderate Alzheimer's disease. About 670 participants will use the device at home for an hour daily over a year, with half receiving a sham (inactive) …
Sponsor: Cognito Therapeutics, Inc. • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
Could a new pill break up Alzheimer's brain clumps?
Disease control CompletedThis study tests a new drug called PRI-002 in 304 people with mild memory problems or early Alzheimer's. The drug aims to break apart harmful protein clumps in the brain that are linked to Alzheimer's. Researchers want to see if it is safe and can slow down memory and thinking de…
Phase 2 • Sponsor: PRInnovation GmbH • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Gene therapy targets Alzheimer's in High-Risk group
Disease control CompletedThis early-stage trial tested a gene therapy called LX1001 in 15 people with Alzheimer's who have two copies of the APOE4 gene, a high-risk form. The therapy delivers a healthy APOE2 gene to try to change the course of the disease. The main goal was to check safety and side effec…
Phase 1/2 • Sponsor: Lexeo Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Simple blood test could spot Alzheimer's early
Diagnosis CompletedThis study is working on a blood test to help diagnose Alzheimer's disease. Researchers are measuring two specific markers in the blood of 200 people—some with Alzheimer's and some healthy—to see if these markers can reliably tell the difference. The goal is to create a simple, n…
Sponsor: Amoneta Diagnostics SAS • Aim: Diagnosis
Last updated Jun 27, 2026 08:05 UTC
-
R2D2 trial: deprescribing anticholinergics may shield aging brains
Prevention CompletedThis study tests whether a pharmacist-led program to stop certain medications (anticholinergics) can lower dementia risk in older adults. 344 participants aged 65+ who take these drugs will be followed for 2 years, comparing cognitive changes and quality of life between those who…
Sponsor: Indiana University • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC
-
Light therapy shows promise for Alzheimer's prevention
Symptom relief CompletedThis study tests if shining a special near-infrared light on the head and through the nose can improve memory and brain function in older adults at risk for Alzheimer's disease. The treatment, called photobiomodulation, is low-risk and aims to boost brain cell energy. 168 partici…
Phase 2 • Sponsor: University of Florida • Aim: Symptom relief
Last updated Sep 21, 2026 17:00 UTC
-
Acupuncture needles vs. sham: does it really help Alzheimer's?
Symptom relief CompletedThis study tested whether adding acupuncture to standard care can slow down memory and thinking problems in people with mild Alzheimer's disease. Researchers compared real acupuncture to a fake (sham) procedure in 160 participants to see if the effects were real or just a placebo…
Sponsor: Shanghai Institute of Acupuncture, Moxibustion and Meridian • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Music as medicine: personalized tunes may boost brain function in Late-Stage Alzheimer's
Symptom relief CompletedThis study tested whether listening to personalized music can improve thinking and daily function in people with advanced-stage Alzheimer's disease. Researchers enrolled 54 older adults and had them listen to either their favorite music or a classical piece. The goal was to see i…
Sponsor: Okan University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Sleep hack may slow Alzheimer's: early study tests Time-in-Bed restriction
Knowledge-focused CompletedThis study tests whether spending less time in bed for four weeks can deepen sleep and boost memory in adults aged 65-85 who have poor sleep and are at risk for Alzheimer's. Researchers will measure brain activity, memory, and blood markers. The goal is to see if a simple behavio…
Early phase 1 • Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jul 08, 2026 00:00 UTC
-
Hunt for hidden genes behind early Alzheimer's
Knowledge-focused CompletedThis study looked at families with at least two members who developed Alzheimer's before age 65. Researchers wanted to find new genes that cause the disease, beyond the three already known. They collected medical and genetic information from 150 people across 23 centers in France…
Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
DNA hunt for early Alzheimer's clues
Knowledge-focused CompletedThis study collected blood and DNA samples from 26 people with early-onset Alzheimer's disease and their close family members. Researchers analyzed the samples to find genetic changes and biomarkers that could help doctors diagnose, treat, and monitor the disease in the future. T…
Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Could changing your gut bacteria protect your memory?
Knowledge-focused CompletedThis study looked at the gut microbiome (the bacteria living in the digestive tract) of 44 people with mild cognitive impairment, early Alzheimer's, or healthy memory. Researchers wanted to see if lifestyle changes could alter the gut microbiome and whether those changes might be…
Sponsor: George Washington University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Planning ahead: study tests if care wishes are honored
Knowledge-focused CompletedThis study looked at whether a special planning tool, called a POST form, helps older adults (65+) get the medical care they prefer at the end of life. Researchers worked with 389 people, including those with dementia, to see if their treatment matched their wishes. The goal was …
Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC